Stock Track | Tandem Diabetes Care Drops Despite Record Q3 Sales on Conservative 2025 Outlook

Stock Track11-07

Tandem Diabetes Care (TNDM) experienced a 5.08% decline in its stock price on November 7, 2024, despite reporting record quarterly sales in the third quarter of 2024. The company's shares fell amid investor concerns over its conservative guidance for 2025 and uncertainties surrounding the potential impact of its new initiatives.

For the third quarter, Tandem Diabetes Care achieved record sales of $244 million, representing a 31% year-over-year increase, driven by strong demand for its innovative products, including the newly launched Tandem Mobi insulin pump. The company's performance was bolstered by solid growth in both the United States and international markets.

While Tandem raised its full-year 2024 sales guidance to a range of $903 million to $910 million, reflecting an increase of 17% to 18% compared to the previous year, the company's outlook for 2025 was met with caution by investors. Tandem Diabetes Care plans to provide conservative guidance for 2025, initially focusing on predictable revenue streams from supply sales and renewals, before factoring in potential benefits from new growth opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162847928?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-07 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162847928","market":"us","top_or_hot":-1,"title":"Stock Track | Tandem Diabetes Care Drops Despite Record Q3 Sales on Conservative 2025 Outlook","media":"Stock Track","content":"<p>Tandem Diabetes Care (TNDM) experienced a 5.08% decline in its stock price on November 7, 2024, despite reporting record quarterly sales in the third quarter of 2024. The company's shares fell amid investor concerns over its conservative guidance for 2025 and uncertainties surrounding the potential impact of its new initiatives.</p>\n\n<p>For the third quarter, Tandem Diabetes Care achieved record sales of $244 million, representing a 31% year-over-year increase, driven by strong demand for its innovative products, including the newly launched Tandem Mobi insulin pump. The company's performance was bolstered by solid growth in both the United States and international markets.</p>\n\n<p>While Tandem raised its full-year 2024 sales guidance to a range of $903 million to $910 million, reflecting an increase of 17% to 18% compared to the previous year, the company's outlook for 2025 was met with caution by investors. Tandem Diabetes Care plans to provide conservative guidance for 2025, initially focusing on predictable revenue streams from supply sales and renewals, before factoring in potential benefits from new growth opportunities.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tandem Diabetes Care Drops Despite Record Q3 Sales on Conservative 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tandem Diabetes Care Drops Despite Record Q3 Sales on Conservative 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-07 22:50 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tandem Diabetes Care (TNDM) experienced a 5.08% decline in its stock price on November 7, 2024, despite reporting record quarterly sales in the third quarter of 2024. The company's shares fell amid ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNDM","symbol_name":"糖尿病保健","start_time":0,"source_url":"","article_id":"1162847928","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162847928","pubTimestamp":1730991046,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tandem Diabetes Care  experienced a 5.08% decline in its stock price on November 7, 2024, despite reporting record quarterly sales in the third quarter of 2024. The company's shares fell amid investor concerns over its conservative guidance for 2025 and uncertainties surrounding the potential impact of its new initiatives.For the third quarter, Tandem Diabetes Care achieved record sales of $244 million, representing a 31% year-over-year increase, driven by strong demand for its innovative produc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNDM":"糖尿病保健"},"translate_title":"尽管2025年前景保守，第三季度销售额创历史新高，但Tandem糖尿病护理仍下跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":1},"content_text":"Tandem Diabetes Care (TNDM) experienced a 5.08% decline in its stock price on November 7, 2024, despite reporting record quarterly sales in the third quarter of 2024. The company's shares fell amid investor concerns over its conservative guidance for 2025 and uncertainties surrounding the potential impact of its new initiatives.\nFor the third quarter, Tandem Diabetes Care achieved record sales of $244 million, representing a 31% year-over-year increase, driven by strong demand for its innovative products, including the newly launched Tandem Mobi insulin pump. The company's performance was bolstered by solid growth in both the United States and international markets.\nWhile Tandem raised its full-year 2024 sales guidance to a range of $903 million to $910 million, reflecting an increase of 17% to 18% compared to the previous year, the company's outlook for 2025 was met with caution by investors. Tandem Diabetes Care plans to provide conservative guidance for 2025, initially focusing on predictable revenue streams from supply sales and renewals, before factoring in potential benefits from new growth opportunities.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162847928"}